255 related articles for article (PubMed ID: 34188523)
1. KRT7 Overexpression is Associated with Poor Prognosis and Immune Cell Infiltration in Patients with Pancreatic Adenocarcinoma.
Li Y; Su Z; Wei B; Liang Z
Int J Gen Med; 2021; 14():2677-2694. PubMed ID: 34188523
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics analysis identified MMP14 and COL12A1 as immune-related biomarkers associated with pancreatic adenocarcinoma prognosis.
Li Y; Su Z; Wei B; Qin M; Liang Z
Math Biosci Eng; 2021 Jun; 18(5):5921-5942. PubMed ID: 34517516
[TBL] [Abstract][Full Text] [Related]
3. High expression of RNF169 is associated with poor prognosis in pancreatic adenocarcinoma by regulating tumour immune infiltration.
Wang J; Chen H; Deng Q; Chen Y; Wang Z; Yan Z; Wang Y; Tang H; Liang H; Jiang Y
Front Genet; 2022; 13():1022626. PubMed ID: 36685833
[No Abstract] [Full Text] [Related]
4.
Kuang W; Wang X; Ding J; Li J; Ji M; Chen W; Wang L; Yang P
Front Immunol; 2022; 13():805311. PubMed ID: 35154122
[TBL] [Abstract][Full Text] [Related]
5. AQP5 Is a Novel Prognostic Biomarker in Pancreatic Adenocarcinoma.
Chen G; Song H; Yang Z; Du T; Zheng Y; Lu Z; Zhang K; Wei D
Front Oncol; 2022; 12():890193. PubMed ID: 35619903
[TBL] [Abstract][Full Text] [Related]
6. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of CENPL mRNA potentially regulated by miR-340-3p predicts the prognosis of pancreatic cancer patients.
Cui Z; Du L; Wang J; Li Z; Xu J; Ou S; Li D; Li S; Hu H; Chen G; Wu Z
BMC Cancer; 2022 Dec; 22(1):1354. PubMed ID: 36572856
[TBL] [Abstract][Full Text] [Related]
8. Integrate analysis of the promote function of Cell division cycle-associated protein family to pancreatic adenocarcinoma.
Xing C; Wang Z; Zhu Y; Zhang C; Liu M; Hu X; Chen W; Du Y
Int J Med Sci; 2021; 18(3):672-684. PubMed ID: 33437202
[No Abstract] [Full Text] [Related]
9. Clinical significance of KRT7 in bladder cancer prognosis.
Song J; Wu Y; Chen Z; Zhai D; Zhang C; Chen S
Int J Biol Markers; 2024 Jun; 39(2):158-167. PubMed ID: 38321777
[TBL] [Abstract][Full Text] [Related]
10. PANX1 is a potential prognostic biomarker associated with immune infiltration in pancreatic adenocarcinoma: A pan-cancer analysis.
Bao L; Sun K; Zhang X
Channels (Austin); 2021 Dec; 15(1):680-696. PubMed ID: 34796785
[TBL] [Abstract][Full Text] [Related]
11. Transmembrane Protein 170B is a Prognostic Biomarker and Associated With Immune Infiltrates in Pancreatic Adenocarcinoma.
Zhang Z; Shang J; Dai Z; Yao Y; Shi Y; Zhong D; Liang Y; Lai C; Yang Q; Feng T; Huang X
Front Genet; 2022; 13():848391. PubMed ID: 35601487
[No Abstract] [Full Text] [Related]
12. High WFDC3 gene expression is associated with poor prognosis and reduced immune cells infiltration in pancreatic adenocarcinoma: A study using the TCGA database and bioinformatics analysis.
Wu W; Wang J; Hu Z; Zhao Y; Wang X; Bai N; Chen L; Gao P
Medicine (Baltimore); 2023 Oct; 102(42):e35595. PubMed ID: 37861515
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological features, prognostic significance, and associated tumor cell functions of family with sequence similarity 111 member B in pancreatic adenocarcinoma.
Gong Q; Dong Q; Zhong B; Zhang T; Cao D; Zhang Y; Ma D; Cai X; Li Z
J Clin Lab Anal; 2022 Dec; 36(12):e24784. PubMed ID: 36408702
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Values and Clinical Significance of S100 Family Member's Individualized mRNA Expression in Pancreatic Adenocarcinoma.
Li X; Qiu N; Li Q
Front Genet; 2021; 12():758725. PubMed ID: 34804125
[No Abstract] [Full Text] [Related]
15. Construction of a novel model based on cell-in-cell-related genes and validation of KRT7 as a biomarker for predicting survival and immune microenvironment in pancreatic cancer.
Song J; Ruze R; Chen Y; Xu R; Yin X; Wang C; Xu Q; Zhao Y
BMC Cancer; 2022 Aug; 22(1):894. PubMed ID: 35974300
[TBL] [Abstract][Full Text] [Related]
16. Identify potential prognostic indicators and tumor-infiltrating immune cells in pancreatic adenocarcinoma.
Shi T; Gao G
Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35083488
[TBL] [Abstract][Full Text] [Related]
17. Analysis and validation of the potential of the MYO1E gene in pancreatic adenocarcinoma based on a bioinformatics approach.
Liu S; Liu P; Fei X; Zhu C; Hou J; Wang X; Pan Y
Oncol Lett; 2023 Jul; 26(1):285. PubMed ID: 37274465
[TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic impact of FZDs in pancreatic adenocarcinoma.
Li Y; Liu Z; Zhang Y
BMC Gastroenterol; 2021 Feb; 21(1):79. PubMed ID: 33618667
[TBL] [Abstract][Full Text] [Related]
19. Deoxythymidylate kinase (DTYMK) participates in cell cycle arrest to promote pancreatic adenocarcinoma progression regulated by miR-491-5p through TP53 and is associated with tumor immune infiltration.
Bao W; Yang H; Zhou S; Huang F; Wei Z; Peng Z
J Gastrointest Oncol; 2023 Jun; 14(3):1546-1559. PubMed ID: 37435228
[TBL] [Abstract][Full Text] [Related]
20. The Prognostic Value and the Oncogenic and Immunological Roles of Vacuolar Protein Sorting Associated Protein 26 A in Pancreatic Adenocarcinoma.
Hou J; Wu H; Xu B; Shang J; Xu X; Li G; Zhang H; Zhang W; Deng Y; Hong X; Hu T; Zhang M; Zhan Y
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]